Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SCGB2A2 - Psoriasis response to brodalumab: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors
SCGB2A2 - Human epidermal growth factor receptor 2-positive breast cancer brain metastases
SCGB2A2 - NeOAdjuvant Herceptin (NOAH) trial: formalin-fixed, paraffin-embedded breast cancer biopsies
SCGB2A2 - Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response
SCGB2A2 - Pregnancy-associated breast cancer: laser capture microdissected epithelia and stroma
SCGB2A2 - Breast cancer metastases from different anatomical sites: fine-needle aspiration biopsies
SCGB2A2 - Lymph node-positive, early stage cervical cancer
GEO DataSets Gene Chromosome neighbors
SCGB2A2 - Psoriasis lesional and non-lesional skin
SCGB2A2 - Stage I endometrial cancer: microdissected frozen uterine tumors
SCGB2A2 - Squamous cell carcinoma of the tongue: tumors and histologically normal surgical margins
SCGB2A2 - Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
SCGB2A2 - Anti-IL-17 monclonal antibody ixekizumab effect on chronic psoriasis
SCGB2A2 - Pretreatment breast needle biopsies of locally advanced breast cancer
SCGB2A2 - Reactive stroma of breast and prostate cancer
SCGB2A2 - Anastrozole/Fulvestrant/Gefitinib neoadjuvant therapy of estrogen receptor positive breast cancer patients: tumor core biopsies
SCGB2A2 - Variable breast cancer tumor sample collection methods
SCGB2A2 - Lapatinib-resistant HER2-positive breast tumor cells
SCGB2A2 - Triple negative breast cancer
SCGB2A2 - ER-positive/HER2-negative and ER-negative/HER2-negative breast cancer biopsies (MDACC/IGR cohort)
SCGB2A2 - ER-positive/HER2-negative and ER-negative/HER2-negative breast cancer biopsies (USO-02103 cohort)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on